 Pharmacogenetics
"Pharmacogenetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).
| Descriptor ID |
D010597
|
| MeSH Number(s) |
H01.158.273.343.750 H01.158.703.052 H02.628.479
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pharmacogenetics".
Below are MeSH descriptors whose meaning is more specific than "Pharmacogenetics".
This graph shows the total number of publications written about "Pharmacogenetics" by people in this website by year, and whether "Pharmacogenetics" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 4 | 1 | 5 | | 2005 | 1 | 5 | 6 | | 2006 | 3 | 2 | 5 | | 2007 | 2 | 2 | 4 | | 2008 | 5 | 1 | 6 | | 2009 | 1 | 4 | 5 | | 2010 | 4 | 3 | 7 | | 2011 | 3 | 2 | 5 | | 2012 | 2 | 3 | 5 | | 2013 | 0 | 3 | 3 | | 2014 | 3 | 2 | 5 | | 2015 | 3 | 3 | 6 | | 2016 | 4 | 6 | 10 | | 2017 | 4 | 3 | 7 | | 2018 | 1 | 4 | 5 | | 2019 | 6 | 2 | 8 | | 2020 | 3 | 2 | 5 | | 2021 | 5 | 4 | 9 | | 2022 | 3 | 1 | 4 | | 2023 | 0 | 3 | 3 | | 2024 | 6 | 4 | 10 | | 2025 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Pharmacogenetics" by people in Profiles.
-
Smith DM, Douglas MP, Aquilante CL, Deverka PA, Devine B, Dunnenberger HM, Empey PE, Hertz DL, Monte AA, Moyer AM, Patel JN, Pratt VM, Saulsberry L, Scott SA, Voora D, Woodahl EL, Whirl-Carrillo M, Oni-Orisan A. Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges. Clin Pharmacol Ther. 2025 Oct; 118(4):778-789.
-
Jones MK, Nicklawsky A, Shortt J, Pattee J, Kennerley V, Eule CJ, Candelario N, O'Donnell PH, Flaig TW. Pharmacogenomics of chemotherapy induced peripheral neuropathy using an electronic health record-derived definition: a genome-wide association study. Support Care Cancer. 2025 Apr 08; 33(5):362.
-
Wichman ML, Wall DM, Garcia Mota SS, Killam SR, Brown KE, Aagaard K, Swaney J, Muzquiz LI, Corum BN, Claw KG, Woodahl EL. Perspectives on Using Pharmacogenomics to Guide Tobacco Cessation: Survey Results From an American Indian Community. Clin Transl Sci. 2025 Mar; 18(3):e70194.
-
Pauck D, Picard D, Maue M, Taban K, Marquardt V, Blümel L, Bartl J, Qin N, Kubon N, Schöndorf D, Meyer FD, Theruvath J, Mitra S, Hasselblatt M, Frühwald MC, Reifenberger G, Remke M. An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT). Pharmacol Res. 2025 Mar; 213:107660.
-
Cavallari LH, Hicks JK, Patel JN, Elchynski AL, Smith DM, Bargal SA, Fleck A, Aquilante CL, Killam SR, Lemke L, Ochi T, Ramsey LB, Haidar CE, Ho T, El Rouby N, Monte AA, Allen JD, Beitelshees AL, Bishop JR, Bousman C, Campbell R, Cicali EJ, Cook KJ, Duong B, Tsermpini EE, Girdwood ST, Gregornik DB, Grimsrud KN, Lamb N, Lee JC, Lopez RO, Mazhindu TA, Morris SA, Nagy M, Nguyen J, Pasternak AL, Petry N, van Schaik RHN, Schultz A, Skaar TC, Al Alshaykh H, Stevenson JM, Stone RM, Tran NK, Tuteja S, Woodahl EL, Yuan LC, Lee CR. The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation. Pharmacogenet Genomics. 2025 Jan 01; 35(1):1-11.
-
Sherman CA, Claw KG, Lee SB. Pharmacogenetic analysis of structural variation in the 1000 genomes project using whole genome sequences. Sci Rep. 2024 10 01; 14(1):22774.
-
Grant CW, Marrero-Polanco J, Joyce JB, Barry B, Stillwell A, Kruger K, Anderson T, Talley H, Hedges M, Valery J, White R, Sharp RR, Croarkin PE, Dyrbye LN, Bobo WV, Athreya AP. Pharmacogenomic augmented machine learning in electronic health record alerts: A health system-wide usability survey of clinicians. Clin Transl Sci. 2024 Oct; 17(10):e70044.
-
Ioannou S, Beecham A, Gomez L, Dauer R, Khakoo N, Pascual L, Quintero M, Lopez J, Leavitt JS, Solis N, Ortega M, Deshpande AR, Kerman DH, Proksell S, Torres EA, Haritunians T, Li D, Abreu MT, McGovern DPB, McCauley JL, Damas OM. Ancestral Diversity in Pharmacogenomics Affects Treatment for Hispanic/Latine Populations With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2025 May; 23(6):1008-1018.e7.
-
Russell LE, Claw KG, Aagaard KM, Glass SM, Dasgupta K, Nez FL, Haimbaugh A, Maldonato BJ, Yadav J. Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions. Drug Metab Rev. 2025 Aug; 57(3):272-290.
-
Bae J, Tantawy M, Gong Y, Langaee T, Lartey M, Ganu V, Tachi K, Ojewale O, Obo-Akwa A, Boamah I, Bushman LR, Ellison L, Yang H, Anderson PL, Kwara A. Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection. Antimicrob Agents Chemother. 2024 09 04; 68(9):e0054924.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|